Amag Pharmaceuticals Incorporation operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amag Pharmaceuticals Incorporation with three other
companies in this sector in the United States:
Meridian Bioscience, Inc.
sales of $194.83 million
of which 75%
was US Diagnostics),
of which 100%
was Diagnostic Products), and
of which 54%
was Animal Safety).
Sales increased substantially in 2015:
Amag Pharmaceuticals Incorporation reported sales of $418.28 million
December of 2015.
increase of 236.3%
versus 2014, when the company's sales were $124.38 million.